Attributes | Values |
---|
rdf:type
| |
description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 2010 (ast)
- наукова стаття, опублікована в січні 2010 (uk)
- مقالة علمية نشرت في 19 يناير 2010 (ar)
- scientific article published on 19 January 2010 (en)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - Axel Hauschild
- Peter Hersey
- David McDermott
- John M Kirkwood
- Jesus Gomez-Navarro
- Margaret A Marshall
- Jane Q Liang
- Cecile A Bulanhagui
|
rdfs:label
| - Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (en)
- Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (nl)
- Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (ast)
|
skos:prefLabel
| - Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (en)
- Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (nl)
- Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (ast)
|
name
| - Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (en)
- Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (nl)
- Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (ast)
|
author
| |
author
| |
title
| |
title
| - Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1158/1078-0432.CCR-09-2033
|
is about
of | |
is cites work
of | |